Clinical trials

  • KITE-363 for Relapsed and refractory B-cell lymphoma
  • Toxin type A complex of Clostridium botulinum (botulinum toxin A complex) for Erectile dysfunction
  • TUPARSTOBART for Recurrent/metastatic squamous cell carcinoma of the head and neck (PD-L1–positive)
  • MIDOSTAURIN for Acute myeloid leukemia|Myelodysplastic syndrome
  • RIMEGEPANT for Acute migraine
  • CAMIZESTRANT for Advanced breast cancer (estrogen receptor–positive, HER2-negative)
  • Vedolizumab for Ulcerative colitis | Crohn's disease
  • LAUROMACROGOL 400 for Spermatocele|Hydrocele
  • EFEPOETIN ALFA for Anemia due to chronic kidney disease on dialysis
  • CART123 (CD123-targeted autologous CAR T cells) for CD123-positive hematological malignancies|Acute myeloid leukemia|Myelodysplastic syndrome|Blastic plasmacytoid dendritic cell neoplasm|Acute lymphoblastic leukemia
  • LENIOLISIB PHOSPHATE for Activated Phosphoinositide 3-Kinase Delta Syndrome
  • TRALOKINUMAB for Atopic dermatitis | Moderate-to-severe atopic dermatitis